Search

Your search keyword '"Nozza A"' showing total 332 results

Search Constraints

Start Over You searched for: Author "Nozza A" Remove constraint Author: "Nozza A" Topic business.industry Remove constraint Topic: business.industry
332 results on '"Nozza A"'

Search Results

1. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

2. Spontaneous splenic rupture during induction therapy in acute myeloid leukemia: An unusual case

3. Enhancing care for people living with HIV: current and future monitoring approaches

4. Continuous-infusion and outpatient setting: A chance for patients, a challenge for hospital pharmacists

5. HIV-DNA undetectability during chronic HIV infection: frequency and predictive factors

6. Recommendations of the Italian society for infectious and tropical diseases (SIMIT) for adult vaccinations

7. The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort

8. Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT)

9. Genetics of symptom remission in outpatients with COVID-19

10. Rilpivirine plus cobicistat-boosted darunavir as alternative to standard three-drug therapy in HIV-infected, virologically suppressed subjects: Final results of the PROBE 2 trial

11. Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV

12. Exercise ECG for coronary artery disease screening in people living with HIV

13. Use of a novel implantable cardioverter‐defibrillator multisensor algorithm for heart failure monitoring in a COVID‐19 patient: A case report

14. Evaluation of HIV transmission clusters among natives and foreigners living in Italy

15. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

16. Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort

17. Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study)

18. Injection of Bupivacaine into the Pleural and Mediastinal Drains: A Novel Approach for Decreasing Incident Pain After Cardiac Surgery – Montreal Heart Institute Experience

19. Atypical Mature T-Cell Neoplasms: The Relevance of the Role of Flow Cytometry

20. Decrease in Incidence Rate of Hospitalizations Due to AIDS-Defining Conditions but Not to Non-AIDS Conditions in PLWHIV on cART in 2008-2018 in Italy

21. Rapid decrease of SARS-CoV-2 circulation in a large Italian hospital six weeks after the start of the immunization program

22. LearningToAdapt with word embeddings: Domain adaptation of Named Entity Recognition systems

23. HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects from the ICONA Italian Cohort of HIV-Infected Patients

24. Cross-lingual contextualized topic models with zero-shot learning

25. Durability of rilpivirine- versus integrase inhibitor-based regimens in a large cohort of naïve HIV-infected patients starting antiretroviral therapy

26. Multidisciplinary study of sudden unexpected infant death in Liguria (Italy): a nine-year report

27. Durability of Integrase STrand Inhibitor (InSTI)-based regimen in geriatric people living with HIV in the GEPPO cohort

28. Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study

29. Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

30. Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19

31. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors

32. Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort

33. Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort

34. CAGE: Constrained deep Attributed Graph Embedding

35. Impact of MELD Score–Based Organ Allocation on Mortality, Bleeding, and Transfusion in Liver Transplantation: A Before-and-After Observational Cohort Study

36. A case of acute promyelocytic leukemia variant with derivative chromosome 3 der(3)t(3;8) associated with 8q partial gain

37. Impact of genotypic susceptibility score on cART outcomes during primary HIV infection

38. Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL

39. Retracted and Republished: A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy

40. Tumor Immune Microenvironment and Genetic Alterations in Mesothelioma

41. Genetics of symptom remission in outpatients with COVID-19

42. Is there any place for novel agents in treating biliary tract cancer?

43. Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19

44. Congenital anomalies of the kidney and urinary tract in a cohort of 280 consecutive patients with Hirschsprung disease

45. Anti-Tat immunity defines CD4+ T-cell dynamics in people living with HIV on long-term cART

46. Obstetric risk factors for poor neonatal adaptation at birth

47. Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014

48. First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison

49. Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART

50. Rilpivirine plus cobicistat-boosted darunavir as a two-drug switch regimen in HIV-infected, virologically suppressed subjects on steady standard three-drug therapy: a randomized, controlled, non-inferiority trial (PROBE 2)

Catalog

Books, media, physical & digital resources